Core Scientific Analyst Price Targets

Wall Street analyst price targets and consensus rating for Core Scientific (CORZ).

Price Target Range — 11 Quarters

Analyst Consensus — 23 Analysts

1S.Buy

18Buy

4Hold

Consensus RatingBuy# Analysts23Avg. Consensus PT$28Upside to Avg. PT+97.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 16, 2026	Cantor Fitzgerald	Brett Knoblauch	PT Cut	Overweight	$39→$30
Oct 15, 2026	Canaccord Genuity	Joseph Vafi	Maintained	Buy	$36
Oct 15, 2026	BTIG	Gregory Lewis	Maintained	Buy	$38
Oct 14, 2026	Cantor Fitzgerald	Brett Knoblauch	Maintained	Overweight	$39
Sep 23, 2026	UBS	Ryan Gravett	Initiate	Buy	$24
Sep 21, 2026	Rothschild & Co	Alex Haissl	Initiate	Neutral	$16
Sep 17, 2026	Wells Fargo	Eric Luebchow	Initiate	Overweight	$28
Aug 3, 2026	B. Riley Securities	Lucas Pipes	PT Raise	Buy	$33→$42
Jul 30, 2026	Keefe, Bruyette & Woods	Stephen Glagola	Upgrade	Market Perform→Outperform	$25→$28
Jul 29, 2026	Macquarie	Paul Golding	PT Raise	Outperform	$35→$38
Jul 29, 2026	Needham	John Todaro	PT Raise	Buy	$29→$35
Jul 29, 2026	Canaccord Genuity	Joseph Vafi	PT Raise	Buy	$30→$36
Jul 28, 2026	Needham	John Todaro	Maintained	Buy	$29
Jul 28, 2026	BTIG	Gregory Lewis	Maintained	Buy	$38
Jun 25, 2026	BTIG	Gregory Lewis	PT Raise	Buy	$33→$38
Jun 16, 2026	Freedom Broker	Paul Meeks	Initiate	Hold	$33
May 27, 2026	B. Riley Securities	Lucas Pipes	PT Raise	Buy	$30→$33
May 14, 2026	Jefferies	Jonathan Petersen	PT Raise	Buy	$24→$37
May 13, 2026	BTIG	Gregory Lewis	PT Raise	Buy	$23→$33
May 7, 2026	Macquarie	Paul Golding	PT Raise	Outperform	$28→$35

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Cantor Fitzgerald Maintains Overweight on Core Scientific, Lowers Price Target to $30

Cantor Fitzgerald analyst Brett Knoblauch maintains Core Scientific (NASDAQ:CORZ) with a Overweight and lowers the price target from $39 to $30.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Core Scientific, Maintains $38 Price Target

BTIG analyst Gregory Lewis reiterates Core Scientific (NASDAQ:CORZ) with a Buy and maintains $38 price target.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on Core Scientific, Maintains $39 Price Target

Cantor Fitzgerald analyst Brett Knoblauch reiterates Core Scientific (NASDAQ:CORZ) with a Overweight and maintains $39 price target.

Benzinga Newsdesk

Hut 8, TeraWulf, Applied Digital: UBS Sees at Least 30% Upside

UBS rates five AI data center operators Buy, citing lease growth and stronger tenants; TeraWulf, Hut 8 and Applied Digital lead upside.

Erica Kollmann

PRO
UBS Initiates Coverage On Core Scientific with Buy Rating, Announces Price Target of $24

UBS analyst Ryan Gravett initiates coverage on Core Scientific (NASDAQ:CORZ) with a Buy rating and announces Price Target of $24.

Benzinga Newsdesk

PRO
Rothschild & Co Initiates Coverage On Core Scientific with Neutral Rating, Announces Price Target of $16

Rothschild & Co analyst Alex Haissl initiates coverage on Core Scientific (NASDAQ:CORZ) with a Neutral rating and announces Price Target of $16.

Benzinga Newsdesk

Core Scientific Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Core Scientific Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Cantor Fitzgerald Maintains Overweight on Core Scientific, Lowers Price Target to $30

PRO
BTIG Reiterates Buy on Core Scientific, Maintains $38 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Core Scientific, Maintains $39 Price Target

Hut 8, TeraWulf, Applied Digital: UBS Sees at Least 30% Upside

PRO
UBS Initiates Coverage On Core Scientific with Buy Rating, Announces Price Target of $24

PRO
Rothschild & Co Initiates Coverage On Core Scientific with Neutral Rating, Announces Price Target of $16

People Also Watch

People Also Watch

Core Scientific Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Core Scientific Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCantor Fitzgerald Maintains Overweight on Core Scientific, Lowers Price Target to $30

PROBTIG Reiterates Buy on Core Scientific, Maintains $38 Price Target

PROCantor Fitzgerald Reiterates Overweight on Core Scientific, Maintains $39 Price Target

Hut 8, TeraWulf, Applied Digital: UBS Sees at Least 30% Upside

PROUBS Initiates Coverage On Core Scientific with Buy Rating, Announces Price Target of $24

PRORothschild & Co Initiates Coverage On Core Scientific with Neutral Rating, Announces Price Target of $16

People Also Watch

People Also Watch

PRO
Cantor Fitzgerald Maintains Overweight on Core Scientific, Lowers Price Target to $30

PRO
BTIG Reiterates Buy on Core Scientific, Maintains $38 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Core Scientific, Maintains $39 Price Target

PRO
UBS Initiates Coverage On Core Scientific with Buy Rating, Announces Price Target of $24

PRO
Rothschild & Co Initiates Coverage On Core Scientific with Neutral Rating, Announces Price Target of $16